Cite
HARVARD Citation
Eriksen, J. et al. (n.d.). OC-009: Update of the randomised phase III trial DAHANCA 19: Primary C-RT or RT and zalutumumab for squamous cell carcinomas of head and neck. Radiotherapy and oncology. pp. 10-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Eriksen, J. et al. (n.d.). OC-009: Update of the randomised phase III trial DAHANCA 19: Primary C-RT or RT and zalutumumab for squamous cell carcinomas of head and neck. Radiotherapy and oncology. pp. 10-. [Online].